carboplatin,durvalumab,paclitaxel,olaparib,bevacizumab
astrazeneca,merck,roche
['olaparib', 'durva', 'duoo', 'gyn', 'ovarian', 'brca']
3. #duoo: olaparib + durvalumab + chemo + bev, advanced high-grade epithelial ovarian cancer: - improved pfs even without mbrca (37.3 vs 23mos) #gyncsm #ovariancancer #asco23 4/4 
Practice changing 🗣 for community oncologists: w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own. COI: https://t.co/cJOjp0RvQE